Search PubMed⌕ Search

Biomedical subjects

Stephen O'Brien

Publications and source records attributed to Stephen O'Brien.

22 records · Page 2Linked to original sources

Synthesis of monodisperse nanocrystals of manganese oxides.

We report a simple and effective method for the generation of high-quality nanocrystals of manganese oxide, MnO, with an alkyl capping group. MnO is a model system for the theoretical study of electronic and magnetic properties of rock salt oxides. Synthesis of relatively monodisperse nanocrystals of MnO was achieved over a range of sizes between 7 and 20 nm. The nanocrystals are readily dispersed in nonpolar solvents, and their uniformity allows for the formation of superlattices, as observed by TEM. Fitting size evolution/time data with the Lifshitz-Slyozov-Wagner model indicates that the increase in particle size from 7 nm is dominated by diffusion-limited growth. Controlled chemical oxidation can allow for the preparation of nanocrystals of Mn3O4 from MnO. We demonstrate the use of acetate precursors in the preparation of ligand-capped, transition metal oxide nanocrystals (of MnO and FeO), which are safer and more environmentally benign than their metal carbonyl counterparts.

Journal Article↗

Not so NICE for CML.

Explore the source record for details and available documents.

Antineoplastic Agents↗

HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion.

Homozygosity for the 32 base-pair deletion (Delta32/Delta32) in the CCR5 coreceptor gene is associated with incomplete HIV-1 resistance. Six HIV-1-infected Delta32/Delta32 patients have been reported. We report 2 additional Delta32/Delta32-infected individuals, among 106 seroconverters in a vaccine preparedness study. Like the previous 6, these individuals experienced rapid CD4 decline. However, taken together, the 8 patients have neither uniformly high virus load nor rapid progression to AIDS. We obtained five virus isolates from 1 patient at 5, 6, 7, 10, and 12 months after the estimated time of infection. The earliest isolate exhibits the syncytium-inducing (SI) phenotype and exclusive use of the CXCR4 coreceptor, suggesting acquisition of HIV-1 through this coreceptor. Of the remaining 104 seroconverters, 8 were CCR5-Delta32/+ and 96 were CCR5-+/+. Three CCR5-+/+ seroconverters who showed the uncommon pattern of early SI virus and rapid CD4 decline had uniformly high viral load and more heterogeneous coreceptor usage. These results further support the conclusion that Delta32-mediated resistance is incomplete and is associated with acquisition of exclusively-X4 variants of HIV-1. The pathogenic potential of these viruses may be different from late-stage X4 virus or early X4 virus acquired by individuals with other CCR5 genotypes.

Base Pairing↗